GRANTS & AWARDS
Cardiomyopathy remains a poorly understood disease in children and an underfunded research area. The research goals of the Children's Cardiomyopathy Foundation (CCF) is to improve outcomes and quality of life for children with cardiomyopathy by advancing medical knowledge on the disease mechanism and developing more accurate diagnostic methods and targeted therapies.
CCF offers funding for basic science, clinical, population/epidemiologic and translational research on cardiomyopathies affecting children aged 18 years and younger. This includes support for studies focused on the causes, diagnosis or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular and left ventricular non-compaction cardiomyopathy.
View past CCF grant awards.
CCF offers two research grant programs through the Foundation and the American Heart Association.
CCF Research Grant Program
CCF's grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and other major granting institutions.
Principal investigator must hold an M.D., Ph.D. or equivalent degree and reside in the United States or Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.
Funding is available in the range of US$25,000 to US$50,000 for one year of total direct costs. Following the completion of the proposed study, a second year of funding may be requested by application. Upon receipt of a signed CCF letter of agreement and IRB or IACUC approval, CCF will disburse funds in installments during the grant period.
CCF requires a letter of intent in advance of the grant application. The 2013 deadline for Letters of Intent is Friday, June 14 by 5:00 p.m. Eastern Standard Time. Only investigators who have submitted a Letter of Intent and have been invited to submit a formal grant application will be considered for CCF funding.
The submission deadline for full grant applications is Friday, September 6, 2013 by 5:00 p.m. Eastern Standard Time with final award decisions to be made in January 2014. Please refer to the below downloadable documents for more information on the application process and required documents:
Letter of Intent Instructions & Form (pdf)
CCF Grant Requirements & Guidelines (pdf)
Grant award decisions are made through a careful and detailed peer-review selection process led by CCF's Medical Advisors and approved by CCF's Board of Directors. A study's scientific excellence and relevance to primary forms of pediatric cardiomyopathy is key to being selected for research funding. Details about the grant review process can be obtained by downloading CCF's Grant Requirements & Guidelines document.
CCF & American Heart Association
Pediatric Cardiomyopathy Joint Research Award
CCF's joint research program with the American Heart Association (AHA) was established to attract and encourage new investigators to conduct research into pediatric cardiomyopathy.
Funding is limited to AHA's Beginning Grant-in-Aid and Grant-in-Aid applicant requirements.
CCF will provide $35,000 per year for two years to fund one project related to pediatric cardiomyopathy research. The AHA will provide the balance of the funds needed to fully fund the selected award.
Interested parties should submit a Beginning Grant-in-Aid or Grant-in-Aid application to AHA's Regional Affiliate. More information on AHA's focused research program can be found on their website. The 2013 submission deadline starts mid-July and the appropriate AHA regional affiliate should be contacted for the exact application deadline.
AHA will conduct the grant review under their standard peer review system. CCF will then select a project from a list of meritorious Beginning Grant-in-Aid or Grant-in-Aid applications approved for funding.
TOP OF PAGE